
Patients with breast cancer treated with zzso often report an improvement in zzso Similar appetite stimulation is seen in patients treated with some zzso but zzso has a potential advantage over these drugs in that it does not exert a zzso zzso zzso zzso zzso zzso zzso has therefore been compared with zzso in 60 patients with advanced zzso zzso zzso patients in the zzso group and 20 in the zzso group were receiving zzso Patients were treated for 6 weeks and were assessed at weeks 0, 3 and 6 for zzso energy, mood and pain using visual analogue zzso zzso status was assessed by the measurement of serum proteins and zzso zzso score was recorded as a measure of performance zzso There was a significant improvement in appetite in the zzso group between weeks 0 zzso and 3 zzso zzso zzso and 0 and 6 zzso zzso zzso There was no significant improvement in appetite in the zzso zzso Supporting this finding was the significant increase in serum zzso binding zzso and zzso binding protein in the zzso group between weeks 0 and 3 and 0 and 6 zzso zzso zzso and P zzso zzso zzso These two parameters showed no significant change in the zzso zzso There was no change in zzso zzso weight, performance status, energy, mood or pain in either zzso These data indicate that there was a significant increase in appetite in zzso patients with advanced cancer treated with zzso which was reflected in increases in rapid turnover proteins reported to reflect nutritional zzso However, this apparent increase in appetite did not result in improved weight, performance status, energy levels, mood or relief of zzso Further studies to investigate the effect of higher doses of zzso are zzso 

